![Jon Congleton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon Congleton
Verkställande Direktör på
MINERALYS THERAPEUTICS, INC.
Förmögenhet: 22 M $ per 2026-05-31
Profil
Jon Congleton is currently President, Chief Executive Officer & Director at Mineralys Therapeutics, Inc. since 2020.
Mr. Congleton is also Director at Immunic, Inc. starting in 2026, Independent Director at Avalyn Pharma, Inc. starting in 2026, and Operating Partner at Catalys Pacific LLC.
Former roles include President & Chief Executive Officer at Alpine Immune Sciences, Inc., President, Chief Executive Officer & Director at IPI Legacy Liquidation Co. from 2017 to 2020, President, Chief Executive Officer & Director at Nivalis Therapeutics, Inc. from 2014 to 2017, Vice President & General Manager at Teva Neuroscience, Inc., and Senior VP-Global Central Nervous System Disorders at Teva Pharmaceutical Industries Ltd. from 2013 to 2014.
Education includes undergraduate studies at Kansas State University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-13 | 689 321 ( 0,91 % ) | 22 M $ | 2026-05-31 | |
AVALYN PHARMA INC -.--% | 2026-04-29 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Jon Congleton
| Företag | Position | Start |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Verkställande Direktör | 2020-11-01 |
| IMMUNIC, INC. | Direktör/Styrelseledamot | 2026-03-27 |
| AVALYN PHARMA INC. | Direktör/Styrelseledamot | 2026-04-01 |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific invests in companies located in Cayman Islands. The firm targets companies operating in the fields of health services and health technology. It provides financing for early stage capital requirements. | Privat kapitalinvesterare | - |
Tidigare kända positioner av Jon Congleton
| Företag | Position | Slut |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Verkställande Direktör | 2020-05-05 |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Verkställande Direktör | 2017-01-15 |
| ALPINE IMMUNE SCIENCES, INC. | Verkställande Direktör | 2017-01-01 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Försäljning & Marknadsföring | 2014-12-01 |
Teva Neuroscience, Inc.
 Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for neurological disorders | Företagsledare/Principal | - |
Jon Congletons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
50
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
Kansas State University
 Kansas State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Neuroscience, Inc.
Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for neurological disorders | Health Technology |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Catalys Pacific LLC
Catalys Pacific LLC Investment ManagersFinance Catalys Pacific invests in companies located in Cayman Islands. The firm targets companies operating in the fields of health services and health technology. It provides financing for early stage capital requirements. | Finance |
Mineralys Therapeutics, Inc.
 Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
